The scenario planning at Lexeo Therapeutics LXEO Q4 2025 EPS Beats Forecasts GBAB Guggenheim reports Q1 2026 earnings with 14 revenue growth but shares retreat 063 amid cautious investor sentiment US Aviation Sector Policy Intervention Assessment of Proposed Distressed Carrier Support Measures What First FCF is doing to expand margins Q1 2026 Earnings Underperform